He will discuss the advancements in the company's gene-editing technology platform ... Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire.

A baby born with a rare and dangerous genetic disease is growing and thriving after getting an experimental gene editing treatment ... doctors hope the technology can someday help the millions ...

A range of other rare inherited diseases are now likely to be curable by similar procedures, the research team said ...

In this photo provided by the Children’s Hospital of Philadelphia, KJ Muldoon, center, sits with his siblings after a follow up dose of an experimental gene editing treatment at the hospital in ...

Oral and poster presentations will highlight advancements from ElevateBio's two business units: Life Edit, its gene editing and R&D technology business ... industry's most critical challenges. Below ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

CRISPR Therapeutics and Intellia face 2025 volatility, but CRSP’s strong cash and launches make it more attractive than NTLA. Learn more on CRSP and NTLA stocks here.

Fonterra supports the legislation but has asked for an amendment to be made for trade risks to be considered. Photo / PGG Wrightson New Zealand is considering a major overhaul of its genetic ...

Moderna previously reported a summary of the results from the company-sponsored trial in 8,000 people. The mRNA technology is used in approved COVID-19 and RSV shots, but has not yet been approved ...

In ibuprofen, for example, one molecule is effective as a pain reliever, but the mirror image of that same ... significant potential in gene regulation, gene editing, drug delivery and vaccine ...

In ibuprofen, for example, one molecule is effective as a pain reliever, but the mirror image of that same ... significant potential in gene regulation, gene editing, drug delivery and vaccine ...